"Hypoparathyroidism Pipeline"Hypoparathyroidism is a rare endocrine disorder caused by insufficient or absent secretion of parathyroid hormone, leading to hypocalcemia, hyperphosphatemia, and a range ...
Elevated calcium and phosphorus levels after therapy with injectable vitamin D for secondary hyperparathyroidism may accelerate vascular disease and hasten death in patients undergoing long-term ...
NEW ORLEANS — Recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) (Natpara, Shire) was safe and effective over 6 years of continuous use for the treatment of adults with chronic ...
September 22, 2011 (San Diego, California) — Parathyroid hormone (PTH) (1-84) is a safe and effective treatment for hypoparathyroidism for up to 4 years, according to research presented here at the ...
Considerable advances have been made in the understanding of the pathogenesis and treatment of secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD). These include the discovery that ...
In patients with chronic heart failure, the vitamin D metabolite 1,25-dihydroxyvitamin D (1,25(OH)2D), also called calcitriol, and its ratio to parathyroid hormone (PTH 1-84) may help predict ...
Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — Recombinant human parathyroid hormone 1-84 lowered oral calcium and calcitriol dosage over 6 years ...
Humans were made to live naked on the equator. Physically, our bodies miss those direct UVB rays, and if we don’t supplement adequately, we are most likely deficient in a very important hormone: ...
Pharmacological options for hypoparathyroidism (hypoPT) management includes conventional therapy and parathyroid hormone (PTH) replacement. While these are the main options, other adjunctive ...
- 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and 24-hour urine calcium in the normal reference range within 5 days of encaleret treatment initiation compared to 0% ...
Blanket routine calcium supplementation after thyroidectomy was no more effective than selective, parathyroid hormone (PTH)-guided therapy for preventing hypocalcemia in a randomized trial. The ...